Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pentamidine isetionate -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - ketamine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - amikacin -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; mannitol - cancer chemotherapeutic drug - details of indications do not appear in the leaflet as exported from hospira australia

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection - excipient ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; mannitol; water for injections - cancer chemotherapeutic drug - details of the indications do not appear on the leaflet as exported from hospira australia

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - levetiracetam, quantity: 500 mg - injection, concentrated - excipient ingredients: nitrogen; sodium acetate trihydrate; sodium chloride; glacial acetic acid; water for injections - hospira? levetiracetam concentrate for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible. levetiracetam is indicated for: use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation; monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy and add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sulfuric acid; sodium hydroxide - not applicable - to be used as part of the liposome injection kit. details are owned by the licence holder, not hospira.

European Union - English - EMA (European Medicines Agency)

pfizer europe ma eeig - palonosetron hydrochloride - nausea; vomiting; cancer - antiemetics and antinauseants, - palonosetron hospira is indicated in adults for:the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy;the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.palonosetron hospira is indicated in paediatric patients 1 month of age and older for:the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy and prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy.

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira enterprises b.v. - propofol - emulsion for inj/inf - 10 micromol

Ireland - English - HPRA (Health Products Regulatory Authority)

hospira enterprises b.v. - noradrenaline acid tartrate - concentrate for soln for inf - 1 mg/ml - adrenergic and dopaminergic agents